Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

SABR to all oligoprogressive lesions + continuation of current systemic therapy

Patients on the standard arm will be treated as per standard of care in our institution. Treatment options could include switching to next systemic therapy line, best supportive care or continuing on current systemic therapy.